Abstract

Many tumors depend on glutamine for energy. Glutamine metabolism is recognized as a distinctive feature in addition to Warburg effect in tumors. Nuclear medicine molecular tracer techniques represented by positron emission tomography (PET) provide a good means for early diagnosis and prognosis of tumors. PET imaging can detect glutamine metabolism region in tumors noninvasively, which can provide new diagnosis and therapeutics for glutamine-addicted tumors. Key words: Glutamine; Neoplasms; Nuclear medicine; Molecular probes

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call